Walgreens Boots Alliance (DE:W8A)
XETRA:W8A
Holding DE:W8A?
Track your performance easily

Walgreens Boots Alliance (W8A) Stock Forecast & Price Target

8 Followers
See the Price Targets and Ratings of:

W8A Analyst Ratings

Hold
12Ratings
2 Buy
7 Hold
3 Sell
Based on 12 analysts giving stock ratings to
Walgreens
Boots Alliance
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

W8A Stock 12 Month Forecast

Average Price Target

€12.55
▲(19.55% Upside)
Based on 12 Wall Street analysts offering 12 month price targets for Walgreens Boots Alliance in the last 3 months. The average price target is €12.55 with a high forecast of €20.20 and a low forecast of €8.26. The average price target represents a 19.55% change from the last price of €10.50.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"7":"€7","26":"€26","11.75":"€11.75","16.5":"€16.5","21.25":"€21.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":20.2015,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€20.20</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":12.5524775,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€12.55</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":8.26425,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€8.26</span>\n  </div></div>","useHTML":true}}],"tickPositions":[7,11.75,16.5,21.25,26],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2023","6":"Jan<br/>2024","9":"Apr<br/>2024","12":"Jul<br/>2024","25":"Jul<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.146,10.919500000000001,11.693000000000001,12.4665,13.24,14.0135,14.786999999999999,15.5605,16.334,17.1075,17.881,18.6545,19.427999999999997,{"y":20.2015,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.146,10.331113653846154,10.516227307692308,10.701340961538463,10.886454615384617,11.07156826923077,11.256681923076924,11.441795576923077,11.62690923076923,11.812022884615384,11.99713653846154,12.182250192307693,12.367363846153847,{"y":12.5524775,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.146,10.00125,9.8565,9.71175,9.567,9.42225,9.2775,9.132750000000001,8.988000000000001,8.843250000000001,8.698500000000001,8.55375,8.409,{"y":8.26425,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":24.598,"date":1689292800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":25.725,"date":1691107200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":21.097,"date":1693526400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":19.716,"date":1696550400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":19.62,"date":1698969600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.258,"date":1701388800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":21.552,"date":1704412800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":20.509,"date":1706832000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":19.521,"date":1709251200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":17.349,"date":1712275200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":16.361,"date":1714694400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":14.72,"date":1717718400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":10.146,"date":1720137600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€20.20Average Price Target€12.55Lowest Price Target€8.26
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Mizuho Securities
€17.45
Hold
66.16%
Upside
Reiterated
06/27/24
We are reducing our FY24E-FY26E adjusted EPS and lowering our price target to $15 from $19 on WBA following FQ3:24 earnings. The key takeaway from today's call was that, as a result of the macroeconomic backdrop, the retail pharmacy environment remains challenged, and to a worse degree than WBA initially expected. The company announced a strategic review that includes a retail pharmacy action plan, as well as initiatives to simplify its VillageMD footprint. On the positive, the International and U.S. Healthcare segments continue to show improved performance, which should help offset pharmacy pressure going forward. Despite this, we believe a full turnaround and recovery in the core U.S. segment is likely a post-FY25 story. We remain Neutral. For more of our thoughts on the quarter, please see our flash.
Leerink Partners
€15.61€10.1
Hold
-3.80%
Downside
Reiterated
06/27/24
Well at least international and Shields are performing well? There really is no way to sugar-coat the immense challenges that WBA saw not only in the current quarter but in the pathway to rebuild stability in the business. The size of the proverbial band-aid was huge, and with the potential to now close as much as 25% of the store base, we believe the bleeding stemming process will kick into full gear. Will it work? Sitting here today we think it is hard to say with 100% certainty that this will be the last stage of the perpetual WBA turnaround plan. It is an important start as the theme of today's announcements is to cut off the pieces of the business that are losing money (the nonprofitable store base and reduction in VillageMD ownership).
HSBC
€18.37
Sell
74.90%
Upside
Downgraded
02/20/24
Walgreens Boots Alliance Downgraded to Sell Amidst Structural Challenges and Negative Industry Headwinds
Jefferies
€22.96
Hold
118.63%
Upside
Reiterated
10/13/23
Analysts Offer Insights on Healthcare Companies: Champions Oncology (NASDAQ: CSBR), Walgreens Boots Alliance (NASDAQ: WBA) and Harrow Health (NASDAQ: HROW)
Raymond James Analyst forecast on DE:W8A
Unknown Analyst
Not Ranked
Raymond James
Hold
Reiterated
03/26/24

Best Analysts Covering Walgreens Boots Alliance

Which Analyst Should I Follow If I Want to Buy DE:W8A and Sell After:
1 Month
xxx
Success Rate
8/18 ratings generated profit
44%
Average Return
-3.83%
assigned a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 44.44% of your transactions generating a profit, with an average return of -3.83% per trade.
3 Months
xxx
Success Rate
7/12 ratings generated profit
58%
Average Return
+0.43%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 58.33% of your transactions generating a profit, with an average return of +0.43% per trade.
1 Year
Lisa GillJ.P. Morgan
Success Rate
6/12 ratings generated profit
50%
Average Return
+2.17%
reiterated a buy rating 4 months ago
Copying Lisa Gill's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +2.17% per trade.
2 Years
xxx
Success Rate
6/12 ratings generated profit
50%
Average Return
-0.53%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of -0.53% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

W8A Analyst Recommendation Trends

Rating
Mar 24
Apr 24
May 24
Jun 24
Jul 24
Strong Buy
2
3
4
4
4
Buy
1
1
1
0
0
Hold
12
12
11
16
13
Sell
8
5
6
8
7
Strong Sell
0
0
0
0
0
total
23
21
22
28
24
In the current month, W8A has received 4 Buy Ratings, 13 Hold Ratings, and 7 Sell Ratings. W8A average Analyst price target in the past 3 months is €12.55.
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

W8A Financial Forecast

W8A Earnings Forecast

Next quarter’s earnings estimate for W8A is €0.33 with a range of €0.29 to €0.38. The previous quarter’s EPS was €0.58. W8A beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 67.35% of the time in the same period. In the last calendar year W8A has Underperformed its overall industry.
Next quarter’s earnings estimate for W8A is €0.33 with a range of €0.29 to €0.38. The previous quarter’s EPS was €0.58. W8A beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 67.35% of the time in the same period. In the last calendar year W8A has Underperformed its overall industry.

W8A Sales Forecast

Next quarter’s sales forecast for W8A is €32.85B with a range of €31.44B to €33.40B. The previous quarter’s sales results were €33.37B. W8A beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 57.38% of the time in the same period. In the last calendar year W8A has Outperformed its overall industry.
Next quarter’s sales forecast for W8A is €32.85B with a range of €31.44B to €33.40B. The previous quarter’s sales results were €33.37B. W8A beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 57.38% of the time in the same period. In the last calendar year W8A has Outperformed its overall industry.

W8A Stock Forecast FAQ

What is DE:W8A’s average 12-month price target, according to analysts?
Based on analyst ratings, Walgreens Boots Alliance’s 12-month average price target is €12.55.
    What is DE:W8A’s upside potential, based on the analysts’ average price target?
    Walgreens Boots Alliance has 19.55% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Walgreens Boots Alliance a Buy, Sell or Hold?
          Walgreens Boots Alliance has a consensus rating of Hold, which is based on 2 buy ratings, 7 hold ratings and 3 sell ratings.
            What is Walgreens Boots Alliance’s share price target?
            The average share price target for Walgreens Boots Alliance is €12.55. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €20.20 ,and the lowest forecast is €8.26. The average share price target represents 19.55% Increase from the current price of €10.5.
              What do analysts say about Walgreens Boots Alliance?
              Walgreens Boots Alliance’s analyst rating consensus is a Hold. This is based on the ratings of 12 Wall Streets Analysts.
                How can I buy shares of Walgreens Boots Alliance?
                To buy shares of DE:W8A, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis